tiprankstipranks
Trending News
More News >
Inspecs Group Plc (GB:SPEC)
LSE:SPEC

Inspecs Group Plc (SPEC) AI Stock Analysis

Compare
10 Followers

Top Page

GB:SPEC

Inspecs Group Plc

(LSE:SPEC)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 4o)
Rating:54Neutral
Price Target:
72.00p
▲(1.69% Upside)
Inspecs Group Plc's overall stock score is primarily influenced by its financial performance challenges, including declining revenues and negative profitability. Technical analysis provides a more positive outlook with bullish momentum, but valuation remains a concern due to the negative P/E ratio and lack of dividend yield. The absence of earnings call and corporate events data means these factors do not impact the score.
Positive Factors
Business Model Strength
The diversified revenue streams from proprietary and licensed eyewear products provide a stable foundation for long-term growth and resilience against market fluctuations.
Market Position
Strong partnerships with retailers and brands expand market reach and improve distribution efficiency, supporting sustained revenue growth and competitive positioning.
Margin Sustainability
A solid gross profit margin indicates efficient production processes, which can help maintain profitability even as the company faces broader revenue challenges.
Negative Factors
Revenue Decline
Declining revenue growth poses a risk to long-term financial health, potentially impacting investment in innovation and market expansion.
Profitability Challenges
Sustained profitability issues can erode shareholder value and limit the company's ability to reinvest in growth opportunities, affecting long-term viability.
Cash Flow Management
Decreasing free cash flow indicates potential liquidity issues, which could constrain operational flexibility and strategic investments needed for future growth.

Inspecs Group Plc (SPEC) vs. iShares MSCI United Kingdom ETF (EWC)

Inspecs Group Plc Business Overview & Revenue Model

Company DescriptionInspecs Group Plc is a global eyewear design, manufacturing, and distribution company headquartered in the United Kingdom. Operating primarily in the eyewear sector, Inspecs specializes in producing high-quality eyewear frames and sunglasses, along with providing licensing services for various brands. The company has a diverse portfolio that includes both proprietary brands and licensed products, catering to a wide range of consumer preferences in the optical market.
How the Company Makes MoneyInspecs Group Plc generates revenue through multiple key streams. Primarily, the company earns income from the design, manufacture, and sale of eyewear products, including optical frames and sunglasses, which are sold through various retail channels. Additionally, Inspecs engages in licensing agreements, allowing it to partner with established brands to produce and distribute eyewear under those labels, thus expanding its market reach and product offerings. The company also benefits from economies of scale in manufacturing, which helps to reduce costs and increase margins. Strategic partnerships with retailers and other brands further enhance its distribution capabilities, while ongoing investment in product innovation and design helps to attract and retain customers, contributing positively to its revenue growth.

Inspecs Group Plc Financial Statement Overview

Summary
Inspecs Group Plc is facing profitability challenges, with declining revenues and negative net income. The balance sheet reflects manageable leverage but shows a declining equity base. Cash flow generation needs improvement, as indicated by reduced free cash flow. Overall, the company needs to address its profitability and cash flow issues to enhance financial stability.
Income Statement
Inspecs Group Plc experienced a decline in revenue over the past year, with a negative revenue growth rate. The gross profit margin stands at approximately 52.2%, indicating decent production efficiency. However, the company is facing challenges in profitability, as reflected by a negative net profit margin and a declining EBIT margin. The EBITDA margin of 7.9% suggests some operational efficiency, but overall profitability remains under pressure.
Balance Sheet
The balance sheet shows a moderate debt-to-equity ratio of 0.63, suggesting manageable leverage levels. However, the return on equity is negative, indicating a lack of profitability with respect to shareholder investments. The equity ratio of 44.8% reflects a reasonable proportion of equity financing, but the declining equity position over recent years raises concerns about financial stability.
Cash Flow
The company's free cash flow has decreased year-over-year, reflecting challenges in cash generation. The operating cash flow to net income ratio is positive, indicating that the company generates cash from operations despite reporting losses. However, the decline in free cash flow growth rate highlights the need for improved cash flow management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue192.83M198.26M203.29M200.96M182.62M47.41M
Gross Profit87.35M103.45M103.55M122.29M115.77M20.52M
EBITDA16.39M15.75M17.27M8.28M6.05M-4.86M
Net Income-8.19M-4.61M-997.00K-6.32M-6.54M
Balance Sheet
Total Assets203.83M220.25M221.91M292.68M326.36M310.45M
Cash, Cash Equivalents and Short-Term Investments22.67M23.96M20.07M26.80M29.76M32.67M
Total Debt58.64M62.47M62.12M69.78M69.44M63.31M
Total Liabilities114.73M121.56M118.39M162.59M181.13M164.64M
Stockholders Equity89.10M98.69M103.52M130.09M145.22M145.82M
Cash Flow
Free Cash Flow3.12M4.28M6.92M842.00K12.37M-3.37M
Operating Cash Flow4.43M7.20M12.66M5.08M20.02M-748.00K
Investing Cash Flow-1.55M-2.52M-6.18M-4.19M-15.66M-104.40M
Financing Cash Flow-2.38M-426.00K-8.84M-4.40M1.70M128.71M

Inspecs Group Plc Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price70.80
Price Trends
50DMA
71.61
Negative
100DMA
57.92
Positive
200DMA
51.57
Positive
Market Momentum
MACD
-0.63
Positive
RSI
41.64
Neutral
STOCH
25.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:SPEC, the sentiment is Neutral. The current price of 70.8 is below the 20-day moving average (MA) of 74.45, below the 50-day MA of 71.61, and above the 200-day MA of 51.57, indicating a neutral trend. The MACD of -0.63 indicates Positive momentum. The RSI at 41.64 is Neutral, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:SPEC.

Inspecs Group Plc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
£203.00M30.5320.31%3.48%10.80%1.75%
72
Outperform
£41.08M14.6710.86%
69
Neutral
£478.01M52.003.66%1.25%68.03%-18.27%
68
Neutral
£4.80B30.0612.73%2.11%4.18%37.65%
54
Neutral
£70.15M-8.56-3.47%-1.18%-99.50%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
50
Neutral
£55.64M-65.15-11.24%283.74%78.57%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:SPEC
Inspecs Group Plc
69.00
27.50
66.27%
GB:AMS
Advanced Medical Solutions
221.00
32.79
17.42%
GB:CTEC
ConvaTec
246.20
23.89
10.75%
GB:SBTX
SkinBioTherapeutics
21.50
5.50
34.38%
GB:TSTL
Tristel
425.00
40.90
10.65%
GB:KOO
Kooth
114.00
-66.50
-36.84%

Inspecs Group Plc Corporate Events

Business Operations and Strategy
Inspecs Appoints Grant Thornton as New External Auditor
Neutral
Dec 31, 2025

Inspecs Group plc has appointed Grant Thornton UK LLP as its new external auditor following a review of its audit arrangements and a competitive tender process, with the firm to conduct the audit of the company’s financial statements for the year ending 31 December 2025. Ernst & Young LLP has resigned as auditor and has confirmed there are no circumstances related to its departure that need to be brought to shareholders’ attention, signalling a routine change in audit provider rather than one driven by disclosed governance or financial concerns.

The most recent analyst rating on (GB:SPEC) stock is a Hold with a £72.00 price target. To see the full list of analyst forecasts on Inspecs Group Plc stock, see the GB:SPEC Stock Forecast page.

Executive/Board ChangesM&A Transactions
Inspecs adjusts board plans amid proposed takeover by Bidco 1125
Neutral
Dec 31, 2025

Inspecs Group plc has announced changes to its board and executive structure in response to the recommended takeover offer from Bidco 1125 Limited, a vehicle indirectly owned by Luke Johnson and Ian Livingstone. Executive Director Robin Totterman, who had been due to leave the board at year-end, will now remain a director until the offer period concludes, while Senior Independent Director Christopher Hancock will continue as interim chair rather than handing over to Andrea Davis, whose previously announced appointment as non-executive chair has been put on hold but who may join the board if the bid fails. The group also reiterated that Chief Financial Officer Chris Kay, who stepped down from the board at the June AGM, will leave the CFO role once a successor is appointed, underscoring a period of governance flux as Inspecs navigates the proposed acquisition and its potential implications for leadership stability and stakeholder confidence.

The most recent analyst rating on (GB:SPEC) stock is a Hold with a £72.00 price target. To see the full list of analyst forecasts on Inspecs Group Plc stock, see the GB:SPEC Stock Forecast page.

M&A Transactions
Inspecs Group PLC Considers Acquisition Proposals Amid Extended Deadline
Neutral
Nov 20, 2025

Inspecs Group PLC has received multiple unsolicited proposals for acquisition, including offers from H2 Equity Partners and a consortium led by Risk Capital Partners and Ian Livingstone. The company has extended the deadline for these parties to make firm offers, with the highest current proposal being a cash offer of 84 pence per share from H2. Additionally, Safilo Group S.p.A has shown interest in acquiring parts of Inspecs, but their offers were rejected for undervaluing the company. The ongoing discussions and potential acquisitions could significantly impact Inspecs’ market positioning and shareholder value.

The most recent analyst rating on (GB:SPEC) stock is a Hold with a £72.00 price target. To see the full list of analyst forecasts on Inspecs Group Plc stock, see the GB:SPEC Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Inspecs Group plc Reports Improved October Sales Amid Ongoing Challenges
Neutral
Nov 20, 2025

Inspecs Group plc reported a trading update for the ten months ending October 2025, noting an improvement in sales in October despite earlier setbacks. However, ongoing US tariff disruptions and a weak macroeconomic environment are expected to affect product shipment timings, leading the company to forecast a revenue of approximately £191 million and an underlying EBITDA of £17.7 million for the year. The company’s profit forecast remains consistent with its accounting policies and assumptions, with no major changes anticipated in market conditions or operational strategies.

The most recent analyst rating on (GB:SPEC) stock is a Hold with a £72.00 price target. To see the full list of analyst forecasts on Inspecs Group Plc stock, see the GB:SPEC Stock Forecast page.

Business Operations and StrategyM&A Transactions
Inspecs Group Evaluates Strategic Options Amid Proposals
Neutral
Oct 29, 2025

Inspecs Group PLC has received a letter from First Seagull expressing various opinions, following unsolicited proposals from H2 Equity Partners Ltd., a consortium including Risk Capital Partners and Ian Livingstone, and Safilo Group S.p.A. In response, Inspecs has formed a Transaction Committee of independent non-executive directors to evaluate the company’s options, potentially impacting its strategic direction and stakeholder interests.

The most recent analyst rating on (GB:SPEC) stock is a Hold with a £48.00 price target. To see the full list of analyst forecasts on Inspecs Group Plc stock, see the GB:SPEC Stock Forecast page.

Business Operations and StrategyM&A Transactions
Inspecs Group PLC Receives Multiple Acquisition Proposals
Neutral
Oct 23, 2025

Inspecs Group PLC has received unsolicited proposals from H2 Equity Partners Ltd. and a consortium including Risk Capital Partners and Ian Livingstone, indicating potential cash offers for the company’s entire share capital. Additionally, Safilo Group S.p.A. has proposed acquiring Inspecs’ Eschenbach Group and BoDe businesses. While these proposals are non-binding, they suggest strategic interest in Inspecs’ operations, potentially impacting its market position and shareholder value.

The most recent analyst rating on (GB:SPEC) stock is a Hold with a £39.00 price target. To see the full list of analyst forecasts on Inspecs Group Plc stock, see the GB:SPEC Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 19, 2025